Frank Sinicrope

30PUBLICATIONS
152CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersTumour immunologyDeep learning
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (30)

|Apr 17, 2026
Predictors of Immune Checkpoint Blockade Response in dMMR Colorectal Cancer Using an Integrated Immune-Enhanced Multiomics Platform.

|Mar 25, 2026
Atezolizumab plus FOLFOX for Stage III Mismatch Repair-Deficient Colon Cancer.

Frank A Sinicrope, Fang-Shu Ou, Dirk Arnold

|Jan 30, 2026
Tissue-Free Circulating Tumor DNA Assay and Patient Outcome in a Phase III Trial of FOLFOX-Based Adjuvant Chemotherapy (Alliance N0147).

Frank A Sinicrope, Diana Segovia, Nalin Sharma

|Nov 14, 2025
Impact of RAS/BRAFV600E Mutations on the Tumor Immune Microenvironment in Mismatch Repair-Deficient/Microsatellite Instability Colorectal Cancers.

Mohamed E Salem, Alberto Puccini, Elizabeth Mauer

|Aug 06, 2025
Novel CDK2/CDK9 inhibitor fadraciclib targets cell survival and DNA damage pathways and synergizes with encorafenib in human colorectal cancer cells with BRAF(V600E).

Md Mohiuddin, Vanda Póvoa, Rita Fior

|Jul 22, 2025
Analysis of Tumor Microenvironmental Features Between Primary and Synchronous Liver Metastases From Patients With Colorectal Cancers Using a Deep Learning Algorithm.

Oluwadunni E Emiloju, Nathan R Foster, Bahar Saberzadeh Ardestani

Pageof 5

Frequent Collaborators

9 joint publications

Qian Shi

7 joint publications

Richard M Goldberg

7 joint publications

Steven R Alberts

6 joint publications

Rondell P Graham